Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT04383535
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of Covid-19 through qualitative polymerase-reverse transcriptase (qRT-PCR -GeneDX Co, Ltd o similar).
* Imagining-diagnosed pneumonia (Rx or CT scan).
* MSOFA score (Modified SOFA) of 2 or more (modified organic failure assessment)
* Informed consent.
Exclusion Criteria:
* Pregnant women
* Women at reproductive age not willing to avoid unprotected sexual intercourse up to Day 30 after study initiation.
* Women in the breastfeeding period
* Patients receiving experimental treatments under development within 30 days prior to study initiation.
* Patients with a previous history of allergic reactions to blood or blood-components transfusion.
* Diagnosis or clinical suspicion of an alternative microbiological cause for pneumonia besides COVID-19
* Use of systemic corticosteroids within 15 days prior to entering the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04383535
Study Brief:
Protocol Section:
NCT04383535